MedPath

Evaluating the Effect of melatonin on mechanically ventilated COVID 19 patients

Phase 2
Recruiting
Conditions
critical COVID19.
U07.1 COVID-19, virus identified
U07.1 COVI
Registration Number
IRCT20210225050495N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
66
Inclusion Criteria

all covid-19 patients admitted to the ICU
Mechanically ventilated patients
within the first 24 hours of intubation

Exclusion Criteria

liver enzyme more than 5 times of normal upper limit

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In ICU Mortality Percent. Timepoint: At the end of the study. Method of measurement: The Number of Alive patients at the end of the study in each group.;The duration of the mechanical ventilation. Timepoint: at the end of the study. Method of measurement: Calculating the total days of mechanical ventilation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath